(Morrisville, N.C.) Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that it has been named to Inc. Magazine’s 29th annual Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies. Ranked 485, Clinipace is listed among the most successful private companies that have experienced substantial revenue growth over a three year period (2006-2009). (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com, Booth 929), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces that CEO Michael Rosenberg, MD, MPH will join a panel June 14 at the DIA Annual Meeting in Washington, DC. Centralized Monitoring: When Does It Make Sense? will focus on the advantages and requirements of monitoring programs that balance the needs of sponsor companies and investigative sites in phase IIIb to postmarket clinical studies. (more…)

(Durham, N.C.) Michael Rosenberg, founder and CEO of full-service clinical research organization (CRO) Health Decisions (www.HealthDec.com), will explore the implications of a fully adaptive clinical program—one which applies adaptive principles to both design and operations—at Adaptive Designs for Clinical Drug Development, to be held April 28 – 30 in Philadelphia, PA. The Summit will focus solely on adaptive clinical development, providing an opportunity for FDA members and research experts to determine the impact of the recently released FDA guidelines on the topic. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, welcomes South Africa-based CRO ClinResearch to the Agile Clinical Network—a community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces that Moscow-based CRO Congenix has become a certified member of the Agile Clinical Network—a community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies. Congenix joins a group of like-minded CROs employing Agile Clinical Development—Health Decisions’ method of combining adaptive design and adaptive operations—in a drive to cut timelines and increase transparency for multinational trials. (more…)

(Durham, N.C.) “If a drug works, there should be no reason for a clinical trial to fail,” declares a new white paper from Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions. This may seem like common sense, but many potentially valid drugs are denied FDA approval because of flawed clinical data that undermines the validity of overall efficacy and safety findings. Titled “What You Don’t Know Can Hurt You: Five Essentials for Minimizing Clinical Development Risk and Ensuring Your Greatest Chance of Success,” the report shows how untreated quality issues at even a single investigator site can negatively impact the results of an entire study. It identifies the elements that every trial should deem mandatory in order to avoid such unnecessary failure. The white paper is available as a free download from the company’s website at www.HealthDec.com/page/five-essentials. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, has completed enrollment for a Phase II universal flu vaccine study only three weeks after the first site initiation visit and less than three months after the partnership was contracted. If the candidate is proven effective, millions of flu vaccine doses could be produced in a time frame of weeks instead of months, a breakthrough with major positive implications for global populations threatened by seasonal and pandemic influenza strains like the H1N1 Swine Flu. (more…)

(Research Triangle Park, N.C.) Quintiles, the world’s leading biopharmaceutical services company, has launched a new positioning and brand identity, driven by the company’s growing ability to solve customers’ emerging clinical and commercial challenges. In anticipation of the changes currently taking place in the biopharma industry, Quintiles has for some time been evolving and strengthening its own business strategy. The company’s new positioning and brand identity signal and underline changes in both Quintiles’ approach and the industry it serves, captured in the idea of “Navigating the New Health.” (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive methods, will explore the value of adaptive techniques to personalized medicine—one of the most important entrepreneurial and venture opportunities in drug development—at the CED 2010 Biotech Conference. (more…)

(Durham, N.C.) As drug developers face increasing legislative and market pressures to produce more impactful results faster and at lower cost, John Wiley & Sons Publishers announces a new book detailing the latest methods demonstrated to boost efficiency and innovation in clinical research. The Agile Approach to Adaptive Research: Optimizing Efficiency in Clinical Development will be released early 2010 with the aim of educating pharmaceutical, biotech and life science research professionals with new skills crucial to the financial health of the industry and the medical welfare of the global population. (more…)

(Durham, N.C.) Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, congratulates its Chief Information Officer (CIO) Maurice Hagar, who received a 2009 Movers & Shakers award from Business Leader Media. The award recognizes Hagar as a rising leader among Triangle businesses with more than 100 employees. (more…)